PATENT CLAIM ANALYSIS

Application Number: 15971127
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-08
Patent Classification: ["424", "133100"]

Abstract:
The invention provides anti-IFNAR1 antibodies with reduced affinity for Fc receptors and/or ligands and methods of making and using such antibodies.

Claim (Index 18):
The antibody of any of  claims 1 - 10 , wherein, said antibody comprise:\n a. a human heavy chain variable region comprising the amino acid sequence of Seq ID No: 28; and b. a human light chain variable region comprising the amino acid sequence of Seq ID No: 30.

Metadata:
- Claim Count in Document: 8.0
- Percentile: 93.0
- Lexical Diversity: 1.1
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15711197', '13431489', '13483280', '11203251', '15714585']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6990257345919989
- 35 USC 102 Novelty (BERT): 0.6793900869747399
- Combined Prediction Score: 0.697062169830273
- Mean Citation Score: 445.23375
- Max Citation Score: 850.0428
- Similarity Product: 652.6018368385793

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test